GH / Guardant Health: Positive ECLIPSE Data Signals More Upside

Guardant Health's various products are all designed to help physicians and patients fight cancer. The company's revenue growth has been good, but its more_horizontal

Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help th more_horizontal

Analysts at both Bernstein and Piper Sandler had good things to say about Guardant Health this week. Shares of the precision oncology company had plun more_horizontal

Guardant Health stock has lost half its value over the past year. That's the bad news. more_horizontal

The average of price targets set by Wall Street analysts indicates a potential upside of 42.1% in Guardant Health (GH). While the effectiveness of thi more_horizontal

Guardant Health, Inc. (NASDAQ:GH ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy more_horizontal

Guardant Health (GH) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to loss o more_horizontal

Guardant Health's share price has been volatile over the past year, but with strong clinical volume growth, the company presents an interesting invest more_horizontal